Visit PandemicFlu.gov for information about pandemic and avian flu.
TAMIFLU is indicated for the treatment of uncomplicated acute illness due to
influenza infection in patients 1 year and older who have been symptomatic
for no more than 2 days.
TAMIFLU is indicated for prophylaxis of influenza in patients 1 year and older.
TAMIFLU is not a substitute for early and annual influenza vaccination.1
About TAMIFLU
Learn about the indications, safety, dosing and administration of TAMIFLU:
About Influenza
Learn more about the clinical profile, impact, diagnosis and management of influenza:
Track the Flu
Help protect your patients by knowing when influenza is in your area.
Track the Flu
THIS SITE IS INTENDED FOR U.S. AUDIENCES ONLY.
Copyright © 2007 Roche Laboratories Inc. All rights reserved. Use
and access of this site is subject to the terms and conditions as set out in
our Legal Statement and Privacy Statement.